Contact this trialFirst, we need to learn more about you.
Nucleoside Analog
Venetoclax Combination Therapy for Blood Cancers
Recruiting1 awardPhase 1
Aurora, Colorado
This trial is testing a new cancer drug, venetoclax, to see if it is safe and effective when used with other cancer drugs to treat pediatric and young adult patients with blood cancers including myelodysplastic syndrome (MDS), acute myeloid leukemia derived from myelodysplastic syndrome (MDS/AML), and acute lymphoblastic leukemia (ALL)/lymphoblastic lymphoma (LBL).
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service